ACVRL1: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
Line 24: Line 24:


{{pharmacology-stub}}
{{pharmacology-stub}}
{{No image}}

Revision as of 05:24, 10 February 2025

ACVRL1 (Activin A receptor type II-like 1) is a protein that in humans is encoded by the ACVRL1 gene. This gene is also known by several other names, including ALK1 and HHT2. The ACVRL1 protein is a type of receptor that is involved in the TGF beta signaling pathway, which plays a crucial role in cellular function and development.

Function

The ACVRL1 protein is a receptor for members of the transforming growth factor-beta (TGF-beta) family. TGF-beta is a cytokine that regulates a wide range of biological processes including cell growth, differentiation, apoptosis, and homeostasis. The ACVRL1 protein is part of the TGF-beta signaling pathway, which is involved in a variety of cellular functions including cell growth, cell differentiation, apoptosis, cellular homeostasis and other cellular functions.

Clinical significance

Mutations in the ACVRL1 gene are associated with hereditary hemorrhagic telangiectasia type 2 (HHT2), a multisystemic vascular dysplasia. This condition is characterized by recurrent epistaxis (nosebleeds), telangiectases in skin and mucosa, arteriovenous malformations in lungs, liver and brain, and gastrointestinal bleeding.

See also

References

<references />

External links

This article is a stub related to pharmacology. You can help WikiMD by expanding it!